Literature DB >> 3846592

The influence of single dose intravenous antibiotics on faecal flora and emergence of Clostridium difficile.

N S Ambrose, M Johnson, D W Burdon, M R Keighley.   

Abstract

The influence of a single intravenous dose of antibiotic on faecal flora and the emergence of Clostridium difficile was studied in volunteers. Seventy-eight volunteers (13 groups of 6 receiving 5 penicillins and 8 cephalosporins) were given a single intravenous dose of antibiotic. Results were compared with a control group of 6 volunteers who did not receive an antibiotic. Changes in the faecal flora were monitored over two weeks. Only cephalosporins were associated with emergence of Cl. difficile, penicillins and controls were not. Frequency of emergence of Cl. difficile in the 6 volunteers in each of the cephalosporin groups were as follows: cephaloridine 0, cephazolin, 1 cefuroxime 1, cefoxitin 2, cefotaxime 2, latamoxef 3, ceftriaxone 2, cefotetan 4. Latamoxef (moxalactam) was associated with a significant rise in total aerobic bacterial counts largely due to increased counts of enterococci. Cefotetan eliminated Escherichia coli and Bacteroides fragilis from the faecal flora three days after administration.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3846592     DOI: 10.1093/jac/15.3.319

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  19 in total

1.  Effects of ceftriaxone on faecal flora: analysis by micromorphometry.

Authors:  B C Meijer; G J Kootstra; D G Geertsma; M H Wilkinson
Journal:  Epidemiol Infect       Date:  1991-06       Impact factor: 2.451

Review 2.  Clostridium difficile associated diarrhoea: diagnosis and treatment.

Authors:  John Starr
Journal:  BMJ       Date:  2005-09-03

3.  Cefotaxime i.v. versus oral neomycin-erythromycin for prophylaxis of infections after colorectal operations.

Authors:  D Raahave; P Hesselfeldt; T B Pedersen
Journal:  World J Surg       Date:  1988-06       Impact factor: 3.352

4.  Totally implantable venous access device placement by interventional radiologists: are prophylactic antibiotics necessary?

Authors:  Anne M Covey; Franz W Toro-Pape; Raymond H Thornton; Crystal Son; Joseph Erinjeri; Constantinos T Sofocleous; Lynn A Brody; Karen T Brown; Kent A Sepkowitz; Kent A Septkowitz; George I Getrajdman
Journal:  J Vasc Interv Radiol       Date:  2012-03       Impact factor: 3.464

5.  Factors influencing the development of antibiotic associated diarrhea in ED patients discharged home: risk of administering IV antibiotics.

Authors:  John Patrick Haran; Gregory Hayward; Stephen Skinner; Chris Merritt; David C Hoaglin; Patricia L Hibberd; Shan Lu; Edward W Boyer
Journal:  Am J Emerg Med       Date:  2014-07-30       Impact factor: 2.469

6.  Clostridium difficile in urology.

Authors:  M Hossain; T J Crook; S R Keoghane
Journal:  Ann R Coll Surg Engl       Date:  2008-01       Impact factor: 1.891

7.  Comparison of ceftriaxone, amikacin, and ciprofloxacin in treatment of experimental Yersinia enterocolitica O9 infection in mice.

Authors:  M Jiménez-Valera; C Gonzalez-Torres; E Moreno; A Ruiz-Bravo
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

8.  In vitro susceptibility of Clostridium difficile to new beta-lactam and quinolone antibiotics.

Authors:  A W Chow; N Cheng; K H Bartlett
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

9.  Intravenous teicoplanin does not prevent Clostridium difficile associated diarrhea.

Authors:  C Wenisch; E Etzersdorfer; S Breyer; W Graninger
Journal:  Clin Investig       Date:  1994-11

Review 10.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.